CollPlant Biotechnologies (CLGN) Return on Capital Employed (2018 - 2025)
CollPlant Biotechnologies (CLGN) posted Return on Capital Employed of 52.5% for Q4 2025, down 15.85% on a QoQ basis from 45.32% in Q3 2025, and down 5593.0% year-over-year from 0.96% in Q4 2024.
CollPlant Biotechnologies (CLGN) Return on Capital Employed (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies' Return on Capital Employed history runs 8 years deep, the most recent figure standing at 52.5% for Q4 2025.
- Quarterly Return on Capital Employed fell 5593.0% year-over-year to 52.5% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 52.5% (down 5593.0% YoY) and the FY2025 annual result came in at 95.09%, down 2152.0% from the prior year.
- Return on Capital Employed was 52.5% for Q4 2025 at CollPlant Biotechnologies, down from 45.32% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 121.52% in Q1 2021 and bottomed at 52.5% in Q4 2025.
- A 5-year average of 5.36% and a median of 5.99% in 2023 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2021 — Return on Capital Employed jumped 16812 bps — and 2022, when it plunged 13459 bps.
- CollPlant Biotechnologies' Return on Capital Employed stood at 0.13% in 2021, then tumbled by 20257 bps to 26.52% in 2022, then soared by 87 bps to 3.43% in 2023, then jumped by 200 bps to 3.42% in 2024, then tumbled by 1633 bps to 52.5% in 2025.
- Business Quant data shows CLGN's Return on Capital Employed at 52.5% in Q4 2025, 45.32% in Q3 2025, and 3.42% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -107.40% |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 10.46% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -68.84% |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -52.50% |
| Sep 30, 2025 | -45.32% |
| Dec 31, 2024 | 3.42% |
| Sep 30, 2024 | -8.56% |
| Jun 30, 2024 | -9.30% |
| Mar 31, 2024 | 2.46% |
| Dec 31, 2023 | -3.43% |
| Sep 30, 2023 | -0.45% |
| Jun 30, 2023 | 0.14% |
| Mar 31, 2023 | -28.99% |
| Dec 31, 2022 | -26.52% |
| Sep 30, 2022 | -21.64% |
| Jun 30, 2022 | -16.55% |
| Mar 31, 2022 | -13.08% |
| Dec 31, 2021 | 0.13% |
| Sep 30, 2021 | -3.33% |
| Jun 30, 2021 | 5.56% |
| Mar 31, 2021 | 121.52% |
| Dec 31, 2020 | -109.44% |
| Sep 30, 2020 | -69.90% |